OPPM
Opus Point Partners Management Portfolio holdings
AUM
$46.9M
This Quarter Return
+29.73%
1 Year Return
-4.17%
3 Year Return
+83.22%
5 Year Return
+175.29%
10 Year Return
–
AUM
$64.3M
AUM Growth
+$64.3M
(+73%)
Cap. Flow
+$18.9M
Cap. Flow
% of AUM
29.39%
Top 10 Holdings %
Top 10 Hldgs %
51.17%
Holding
76
New
37
Increased
5
Reduced
25
Closed
2
Top Buys
| 1 |
Direxion Daily S&P Biotech Bull 3X Shares
LABU
|
$1.72M |
| 2 |
Bristol-Myers Squibb
BMY
|
$1.57M |
| 3 |
IMMU
Immunomedics Inc
IMMU
|
$1.2M |
| 4 |
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
|
$1.11M |
| 5 |
uniQure
QURE
|
$848K |
Top Sells
| 1 |
LOXO
Loxo Oncology, Inc
LOXO
|
$870K |
| 2 |
Biogen
BIIB
|
$320K |
| 3 |
Exelixis
EXEL
|
$243K |
| 4 |
Ionis Pharmaceuticals
IONS
|
$177K |
| 5 |
CELG
Celgene Corp
CELG
|
$139K |
Sector Composition
| 1 | Healthcare | 65.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
iShares Biotechnology ETF
IBB
$5.6B
| $14M | 18.94% | 125,000 | – | – |
|
|
2
Direxion Daily S&P Biotech Bull 3X Shares
LABU
$647M
| $5.87M | 7.95% | 98,011 +28,702 | +41% | +$1.72M |
|
3
Mettler-Toledo International
MTD
$26.8B
| $2.34M | 3.17% | 3,235 | – | – |
|
4
ProQR Therapeutics
PRQR
$237M
| $1.92M | 2.6% | 138,461 | – | – |
|
|
5
Ionis Pharmaceuticals
IONS
$6.8B
| $1.63M | 2.21% | 20,124 -2,183 | -10% | -$177K |
|
|
6
Bristol-Myers Squibb
BMY
$96B
| $1.57M | 2.13% | +33,000 | New | +$1.57M |
|
7
Vertex Pharmaceuticals
VRTX
$100B
| $1.49M | 2.01% | 8,074 -590 | -7% | -$109K |
|
8
Illumina
ILMN
$15.8B
| $1.45M | 1.97% | 4,675 -233 | -5% | -$72.4K |
|
|
ALXN
9
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.34M | 1.82% | 9,927 -560 | -5% | -$75.7K |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $1.31M | 1.77% | 17,832 -1,295 | -7% | -$94.8K |
|
11
Alnylam Pharmaceuticals
ALNY
$58.5B
| $1.25M | 1.69% | 13,351 -904 | -6% | -$84.5K |
|
|
IMMU
12
DELISTED
Immunomedics Inc
IMMU
| $1.2M | 1.63% | +62,575 | New | +$1.2M |
|
13
Qiagen
QGEN
$10.1B
| $1.17M | 1.59% | 28,858 -2,605 | -8% | -$106K |
|
|
ONCE
14
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.11M | 1.5% | +9,699 | New | +$1.11M |
|
|
BLUE
15
DELISTED
bluebird bio
BLUE
| $919K | 1.25% | 5,840 +3,106 | +114% | +$489K |
|
16
Incyte
INCY
$16.5B
| $913K | 1.24% | 10,613 -1,592 | -13% | -$137K |
|
17
Regeneron Pharmaceuticals
REGN
$61.5B
| $904K | 1.23% | 2,201 -315 | -13% | -$129K |
|
|
18
uniQure
QURE
$896M
| $848K | 1.15% | +14,215 | New | +$848K |
|
19
BioMarin Pharmaceuticals
BMRN
$11.2B
| $808K | 1.1% | 9,099 -599 | -6% | -$53.2K |
|
|
CELG
20
DELISTED
Celgene Corp
CELG
| $803K | 1.09% | 8,510 -1,473 | -15% | -$139K |
|
21
Insmed
INSM
$28.8B
| $783K | 1.06% | +26,936 | New | +$783K |
|
22
Ascendis Pharma
ASND
$11.8B
| $729K | 0.99% | +6,190 | New | +$729K |
|
|
BOLD
23
DELISTED
Audentes Therapeutics, Inc
BOLD
| $677K | 0.92% | +17,339 | New | +$677K |
|
|
ICPT
24
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $644K | 0.87% | 5,756 +2,222 | +63% | +$249K |
|
|
EPZM
25
DELISTED
Epizyme, Inc
EPZM
| $624K | 0.85% | +50,378 | New | +$624K |
|